Recent Posts
- Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems
- Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors
- Chembio Diagnostics Awarded $12.7 Million by BARDA for Development of Rapid DPP Respiratory Antigen Panel and 510(k) Submission of the Rapid DPP SARS-CoV-2 Antigen Test System
- Chembio Diagnostics Receives ANVISA Approval for DPP SARS-CoV-2 Antigen Test System in Brazil
- Chembio Diagnostics Submits EUA Application for DPP SARS-CoV-2 Antigen Test System
Recent Comments